The Truth Is Out There

Posts tagged ‘covid’

FDA Approves Pfizer’s New XFG COVID Shot Without Human Safety or Efficacy Trial of New Formula—Genetic Sequence Hidden From Public, Raising Informed Consent Alarms


No human trial showing Pfizer’s new XFG shot is safe, prevents COVID-19, or reduces hospitalization or death; and Pfizer has not publicly revealed the complete genetic instructions being injected.

Pfizer CEO Albert Bourla delivers remarks alongside President Donald Trump during a drug-pricing announcement in the Oval Office on Sept. 30, 2025. (Official White House photo by Joyce N. Boghosian)

The U.S. Food and Drug Administration has approved Pfizer and BioNTech’s new “XFG-adapted” COVID-19 vaccine without the companies first demonstrating in a human clinical trial that the specific XFG formulation is safe, effective, or produces the intended immune response in people.

And the complete nucleotide sequence of the mRNA Pfizer wants injected into people has not been made public by the company, meaning recipients are being asked to consent without knowing either how this specific formulation performs in humans or the exact genetic code the shot is designed to instruct their cells to use to produce the claimed XFG spike protein.

And without disclosure of that sequence, its provenance cannot be independently scrutinized: the public cannot verify exactly where the genetic code came from, how it was derived, what engineered changes were introduced, or whether the sequence being manufactured even matches the genetic instructions Pfizer and FDA claim the shot contains.

Pfizer announced Thursday that FDA approved its supplemental Biologics License Application for COMIRNATY XFG for adults 65 and older and people ages 5 through 64 with at least one underlying condition allegedly placing them at what the company calls “high risk” for severe COVID-19.

Pfizer says the approval was based on a “cumulative body of evidence previously submitted” for COMIRNATY (including clinical, nonclinical, and real-world data) along with “manufacturing/quality and non-clinical data” for the new XFG-adapted formulation.

FDA’s own account confirms the divide: for the 2026–2027 vaccine decision, the agency says it considered human immunogenicity data from existing vaccines but “animal immunogenicity data on new candidate vaccines expressing or containing updated spike components.”

The human evidence belonged to earlier vaccine formulations.

For the newly approved XFG formulation, Pfizer presented nonclinical laboratory antibody measurements.

That raises questions:

  • If Americans are going to be injected with the XFG formulation, why was that formulation itself not first tested for safety and efficacy in people?
  • What evidence establishes that the human safety profile and clinical benefit of previous formulations can simply be carried forward to a changed shot?
  • And how much can the product being injected change before FDA requires the new version itself to undergo human testing?

Congressional committees have confirmed that the FDA “is not meeting important federal safety requirements to protect its employees and the public while also failing to prioritize scientific data quality delivered from FDA laboratories.”

You can contact the FDA here.


What Is the Exact Genetic Sequence Being Injected?

Pfizer is asking Americans to receive a newly formulated mRNA vaccine without publicly telling them the complete nucleotide sequence of the genetic material being injected.

The company says the newly approved vaccine “target[s] the XFG variant” and describes Pfizer-BioNTech COVID-19 vaccines as based on BioNTech’s “proprietary mRNA technology.”

But naming XFG does not disclose the alleged genetic sequence inside the shot.

Multiple nucleotide sequences are said to be able to encode the same protein.

That means knowing which variant Pfizer says the vaccine targets does not, by itself, reveal the precise sequence Pfizer manufactured, including any engineered nucleotide choices used to produce the encoded spike protein.

Pfizer says FDA reviewed “manufacturing/quality” information for the new XFG formulation.

Yet the complete nucleotide sequence of the XFG vaccine mRNA is not disclosed in Pfizer’s cited XFG supportive-data presentation or its approval announcement.

So people are being asked to consent to receiving alleged genetic material without Pfizer publicly providing the complete genetic sequence they are being asked to receive.

Which raises questions:

  • What is the complete nucleotide sequence inside the XFG shot?
  • What engineered changes did Pfizer make to it?
  • How does it differ from the sequence of circulating XFG and from Pfizer’s previous LP.8.1 formulation?
  • Why isn’t the exact sequence publicly disclosed so independent scientists can examine it?
  • And how can Americans make a fully informed decision about receiving genetic material when the manufacturer has not publicly disclosed the complete genetic instructions being injected into their bodies?

XFG-Specific Alleged Immune Evidence Came From Mice, Not Humans

Pfizer produced no human clinical immunogenicity trial of the XFG formulation before FDA approved it.

Its May 28 presentation makes the distinction explicit.

The human evidence appears under “LP.8.1 Vaccine Clinical Immunogenicity.”

The new candidate vaccines appear separately under “Preclinical Immunogenicity of Candidate Vaccines.”

Pfizer’s human clinical immunogenicity study involved the previous LP.8.1-adapted vaccine, not XFG.

Pfizer says those human antibody measurements were made with a “validated authentic virus neutralization assay.”

For the new XFG formulation, Pfizer instead presented laboratory antibody measurements from mice.

One slide is titled:

“LP.8.1 and XFG Vaccines Elicit Similar Neutralizing Responses in Naïve Mice; Diminished Against BA.3.2.2.”

The experiment involved just 10 mice per vaccine group, receiving a 0.5-microgram dose, and was said to have measured a 50% neutralization titer using a pseudo virus neutralization assay.

Pfizer also produced similar laboratory antibody measurements in vaccine-experienced mice, again using 10 animals per vaccine group and pseudo virus neutralization.

None of those measurements establishes whether the XFG formulation is safe in humans.

  • They do not establish whether it prevents COVID-19 in humans.
  • They do not establish whether it reduces hospitalization or death.
  • They do not even establish what neutralizing-antibody response the XFG formulation produces in humans.

Pfizer’s own conclusion was narrower:

“LP.8.1 and XFG vaccines exhibited similar patterns of elicited immunity in nonclinical models.”

FDA likewise characterized the XFG evidence as “Nonclinical studies” in its May presentation.

Questions are raised:

  • Why should laboratory antibody measurements from groups of 10 mice against pseudo viruses be enough XFG-specific immune-response evidence to proceed to human approval?
  • What can those measurements actually establish about safety or disease prevention in a human being?
  • And if Pfizer was not required even to demonstrate the new formulation’s intended immune response in people before approval, what XFG-specific evidence could have stopped the shot from reaching the market?

No Human Efficacy Trial of the XFG Shot

Pfizer does present alleged human effectiveness data.

But the people generating those data did not receive the XFG vaccine FDA just approved.

They received the previous LP.8.1 formulation.

Pfizer reports alleged LP.8.1 effectiveness estimates against outpatient and emergency or urgent-care visits and hospitalization.

Pfizer summarizes the evidence this way:

“LP.8.1 vaccine maintained effectiveness during period of XFG predominance.”

That is purported evidence about the previous LP.8.1 shot during a period when XFG was circulating.

It is not an efficacy trial of the XFG shot.

Pfizer does not present a human trial showing that people receiving its new XFG formulation were less likely to become infected, develop COVID-19, be hospitalized, or die.

Nevertheless, the newly approved product is indicated “to protect against coronavirus disease 2019 (COVID-19).”

FDA says its decision was instead based on the “totality of the evidence,” which included alleged current vaccine effectiveness, human immunogenicity evidence from existing vaccines, and animal immunogenicity evidence from the new candidate formulations.

This raises more questions:

  • If nobody receiving the XFG shot was studied for clinical efficacy before approval, what direct evidence establishes how much disease this specific shot prevents?
  • What is its demonstrated reduction in hospitalization or death?
  • How can patients weigh the expected benefit of this formulation when those outcomes were never measured in people receiving it?

No Human Safety Trial of the New XFG Formula

Pfizer does not present a human clinical safety trial of its new XFG formulation.

Instead, Pfizer explicitly says FDA relied on the “cumulative body of evidence previously submitted” for COMIRNATY alongside manufacturing/quality and nonclinical evidence for XFG.

That means previous formulations supply the alleged human safety history being invoked to support the changed formulation.

The distinction is consequential because Pfizer’s own safety information acknowledges that myocarditis and pericarditis have occurred following its mRNA COVID-19 vaccines and says the conditions have occurred most commonly in males ages 12 through 24.

Historical COMIRNATY safety data therefore exist.

But historical safety data from earlier formulations are not observations of what happens to humans after receiving the new XFG formulation.

FDA says it “will continue to monitor the safety and effectiveness of the COVID-19 vaccines.”

That makes the timing of safety evidence an unavoidable question.

  • How could an adverse reaction unique to (or occurring at a different rate with) the XFG formulation have been detected before approval when Pfizer did not conduct an XFG human safety trial?
  • What evidence establishes that changing the encoded antigen cannot alter the shot’s human safety profile?
  • And if an XFG-specific safety signal can only become visible after people start receiving the approved product, how much of the safety question has effectively been pushed from preapproval testing into postmarketing surveillance?

What Would Have Made FDA Say No?

FDA says its XFG recommendation was made “based on the totality of the evidence.”

But FDA’s description of that evidence reveals what the new formulation itself did, and did not, have to demonstrate.

The agency says it considered alleged circulating variants, current vaccine effectiveness, human immunogenicity data from current vaccines, antigenic characterization, human immunogenicity data from the 2025–2026 vaccines, and “animal immunogenicity data on new candidate vaccines.”

FDA’s own May 28 presentation similarly placed its conclusion about XFG under “Nonclinical studies,” claiming that LP.8.1 and XFG vaccines produced cross-neutralizing responses against certain lineages.

Pfizer, meanwhile, acknowledges in its approval announcement that research and development can produce “unfavorable new clinical data” and that regulatory decisions involve determining whether a product’s benefits outweigh its known risks.

But there could be no unfavorable XFG human clinical-trial result before approval if Pfizer was not required to produce such a trial.

There could be no XFG-specific clinical efficacy failure observed in humans if efficacy was not measured in XFG recipients.

And there could be no adverse-event imbalance detected in an XFG clinical trial if no XFG human safety trial was conducted.

More questions are raised:

  • What predetermined human safety or efficacy threshold did the new XFG shot have to meet before FDA would approve it?
  • What XFG-specific evidence could have revealed a problem serious enough to stop approval?
  • If neither human safety nor clinical efficacy had to be demonstrated before approval, exactly what result would have caused FDA to reject the formulation?

Approval First, XFG Human Experience After

Pfizer did not announce that the XFG formulation would undergo human clinical testing before distribution.

It announced immediate shipment.

“This season’s Pfizer and BioNTech COVID-19 vaccine will begin shipping immediately and will be available in pharmacies, hospitals, and clinics across the U.S. in the coming days.”

That means FDA approved the XFG formulation without a human XFG safety trial, human XFG efficacy trial, or human XFG immunogenicity trial, and Pfizer moved directly to distribution.

The first broad human experience with this specific formulation therefore comes after approval, not from a preapproval clinical trial designed to establish its safety or efficacy.

  • If an unexpected XFG-specific safety problem emerges after rollout, who is accountable for deciding human testing was unnecessary before approval?
  • How many recipients might be exposed before a rare adverse event becomes statistically visible?
  • And are patients being clearly told that the specific XFG formulation they are receiving was approved without first being subjected to a human clinical safety or efficacy trial?

Bottom Line

Pfizer’s own evidence draws two critical lines.

First, the company cites human clinical and real-world evidence accumulated from previous COMIRNATY formulations, not human testing of the newly approved XFG shot.

  • For XFG itself, Pfizer presents nonclinical laboratory antibody measurements, including experiments involving groups of just 10 mice whose serum was evaluated against pseudo viruses.
  • Those measurements did not establish the new formulation’s human safety.
  • They did not establish its human efficacy.
  • They did not demonstrate that the XFG shot prevents infection, COVID-19, hospitalization, or death in people.
  • They did not even establish the XFG formulation’s neutralizing-antibody response in humans.

Second, Pfizer has not publicly provided the complete nucleotide sequence of the mRNA in the new XFG shot in the XFG materials cited here.

  • Calling the vaccine “XFG-adapted” does not reveal that sequence.
  • Multiple nucleotide sequences can encode the same protein, meaning the public designation does not disclose the precise genetic instructions Pfizer manufactured or what engineered nucleotide choices were incorporated into them.
  • Without the complete sequence, independent scientists and recipients cannot independently examine its full provenance: exactly where the genetic code came from, how it was derived, what engineered changes were introduced, how it differs from Pfizer’s previous formulation, or whether the manufactured sequence matches the genetic instructions Pfizer and FDA say the product contains.

FDA nevertheless approved the XFG formulation, and Pfizer announced that shipments would begin immediately.

The result is extraordinary: Americans are being asked to receive a newly changed mRNA formulation that was not subjected to a human safety, efficacy, or immunogenicity trial before approval, while the complete nucleotide sequence of the genetic material they are being asked to receive has not been publicly provided in Pfizer’s cited XFG materials.

FDA calls this an update to an already licensed vaccine.

But a regulatory classification cannot answer the underlying empirical or informed-decision questions.

  • What exactly is the complete genetic sequence being injected?
  • What is its independently verifiable provenance?
  • What human evidence establishes that this specific formulation is safe?
  • What human evidence establishes that it prevents disease, hospitalization, or death?
  • How can recipients fully scrutinize what they are consenting to when the complete genetic instructions have not been made public?
  • And if FDA’s assumptions about either the new formulation’s safety or its similarity to previous shots prove wrong only after rollout, who is accountable?

Jeffrey Tucker Found The Motive That Five Years Of Fauci Investigations Missed


On July 29th, Anthony Fauci sat in a Senate hearing room, surrounded by lawyers, and invoked his Fifth Amendment right 111 times. He had been subpoenaed by Senator Rand Paul, who two days earlier had released 1,141 pages of Fauci’s pandemic diaries. The man who spent three years telling Americans that questioning him was questioning science declined to answer questions about what he had done. That image is arresting on its own. But it does not explain anything, and explanation is what has been missing.

Consider the strange shape of the Fauci controversy. For five years, investigators have accumulated an enormous quantity of material. There are grant documents, emails, inspector general findings, congressional depositions, failed predictions, guidance that reversed itself without acknowledgment, and evidence of pressure on dissenting scientists. What there has not been is a coherent account of why. Critics have generally settled for one of two stories, neither satisfying. Either Fauci was an ordinary bureaucrat who made ordinary errors under pressure, which fails to explain the pattern in those errors, or he was a cartoon villain executing a plot, which fails because no document shows anyone planning anything of the kind. Jeffrey Tucker has now supplied the missing piece, and it is worth understanding why his account deserves attention.

Tucker is not a newcomer to this subject. He is the founder and president of the Brownstone Institute, a research organization he established in 2021 specifically to document the consequences of pandemic policy. Before that, he spent decades in economics publishing, working closely with Murray Rothbard, running the Mises Institute’s book program, and writing for the Epoch Times. In 2020, he helped organize the signing of the Great Barrington Declaration at the American Institute for Economic Research, which put him in the room with the scientists Fauci’s circle set out to destroy. He has ten books to his name. More to the point, he spent nearly a full week reading all 1,141 pages of the diaries before writing about them, which is more than most commentators managed, and it shows.

His thesis is stated plainly. Fauci, Tucker argues, was “trying to turn himself from villain to hero in the story of manufactured pathogens should it ever be revealed.” The awards, the media saturation, the lockdowns, the hostility toward cheap therapeutics, the vaccine absolutism, all of it functioned as cover. Fauci made himself the indispensable solution to a problem his own institutional world almost certainly helped create.

Now, a reader might reasonably object that this is a claim about a man’s inner life, and inner lives are not observable. That objection deserves a serious answer, and the answer is that Tucker’s thesis does not require mind reading. It requires only four propositions, each of which rests on the documentary record.

The first is that Fauci was a longtime advocate of research that deliberately enhances dangerous viruses. This is not an inference. In December 2011, Fauci wrote in the Washington Post, together with Francis Collins and Gary Nabel, that “important information and insights can come from generating a potentially dangerous virus in the laboratory.” That was his considered public position, defended under his own name. The federal government found the underlying risks serious enough to pause funding for such work in 2014 and to impose a new oversight framework in 2017.

The second is that his agency carried real institutional exposure. In 2023, the HHS Office of Inspector General audited three NIH awards to EcoHealth Alliance totaling roughly $8 million, including $1.8 million in subawards to eight recipients, among them the Wuhan Institute of Virology. The audit found that NIH identified potential risks and then failed to monitor the awards effectively. A critical progress report arrived nearly two years late. EcoHealth could not obtain full scientific documentation from its Wuhan partner. In January 2025, HHS formally debarred both EcoHealth and Peter Daszak for five years. Whatever one believes about the virus itself, the government’s own auditors concluded the oversight had failed.

The third is that Fauci helped organize the scientific response to the origin question at the exact moment that exposure mattered most. On February 1st, 2020, he joined a private call about the virus’s origins. Kristian Andersen, writing to a Nature editor days later, described the resulting project as “prompted by Jeremy Farrar, Tony Fauci, and Francis Collins.” The paper that emerged, “The Proximal Origin of SARS-CoV-2,” declared flatly that the virus was not a laboratory construct. NIH promoted it. When it failed to end the discussion, Collins asked Fauci whether NIH could do more to put down the lab theory. The next day Fauci cited the paper from the White House podium as though it were an independent finding rather than something his own circle had concocted.

Here is where the argument acquires real force. Privately, the authors were nowhere near as certain as the paper sounded. In June 2020, Andersen wrote that there was “no hard evidence one way or the other,” that deliberate insertion could not be ruled out, and that the paper had been too strong. He noted that Wuhan had cultured bat coronaviruses under BSL-2 conditions and that he considered natural and laboratory scenarios roughly equally probable. In May, Edward Holmes worried about how to warn people about gain-of-function risk without helping the lab leak camp, and Andersen replied, “Exactly, that’s why I haven’t said anything.” Ralph Baric, who knows this research better than almost anyone alive, told Senate investigators this year that he disagreed with the idea that a lab leak could be completely ruled out.

Public certainty, private doubt. That gap is precisely what a reputation management project predicts and what honest inquiry does not.

The fourth proposition is where the diaries earn their keep. They show a man consumed by status. Tucker documents a single day containing 11 media appearances. The pages are thick with celebrity contacts, tributes, awards, and elite access, and thin to the point of absence on the human wreckage below. Fauci records calling the Great Barrington authors, credentialed scientists from Harvard, Stanford, and Oxford, the “3 stooges.” Collins, in a separate email, wanted a “quick and devastating published takedown” of their declaration. These are not the reactions of men weighing evidence. They are the reactions of men defending a franchise.

Put the four together, and the motive is not mysterious at all. Fauci did not need to know the virus came from a laboratory. He needed only to grasp that a serious investigation into that possibility would threaten his agency, his research philosophy, his standing, and his place in history. That recognition alone is sufficient to explain everything that followed.

The thesis also explains something the ordinary-error story cannot: why failure produced escalation instead of humility. The diaries show Fauci knew by January 2021 that mutations were outrunning the formulas. By mid-2021, he acknowledged that the vaccinated were getting infected, then publicly blamed the unvaccinated days later. By July 2022, he noted that Americans were being told to get boosted with a shot that did not cover the circulating variant, with a matched booster five weeks away. A leader whose authority rested on evidence adjusts when the evidence moves. A leader whose identity has fused with the solution treats every disappointment as proof that compliance was insufficient, and so the mandates continued and the messaging hardened and the children who had never been at meaningful risk were enrolled anyway, and none of it can be understood as adaptive public health because it was never adaptive and it was never really about health.

Fauci himself gave the game away in November 2021 when he told CBS that people criticizing him were “really criticizing science because I represent science.” That sentence is the whole era compressed. It is also, as it happens, the clearest confirmation of Tucker’s reading that anyone could have asked for, because it shows the fusion had already occured in Fauci’s own mind.

None of this requires believing that Fauci engineered a virus or ordered its release. Tucker does not claim that, and the case does not need it. What it requires is recognizing that we allowed one man to fund the research, oversee the research, define whether the research was risky, convene the scientists who assessed the origin, promote their conclusion, set the policy response, and serve as the sole authorized interpreter of all of it. No serious system of accountability permits that concentration. A bank does not audit its own books after the crash.

Tucker’s closing judgment is that Fauci “sought immortality through power and fame,” and that his immortality is now earned in infamy. That reads like literary flourish until you sit with the record, and then it reads like a finding. The diaries were assembled, Tucker suspects, as raw material for an autobiography, a monument to a great career. They have become the primary evidence against him. He was preemptively pardoned by Joe Biden. He pleaded the Fifth anyway, 111 times.

Just think about that now.

AI-Designed Needle-Free DNA COVID Vaccine Trial Records 148 Adverse Events Among Just 39 Vaccinated Participants: ‘Journal of Infection’


All participants had already received prior COVID vaccinations, making it impossible to determine whether observed immunity came from the experimental shot, prior vaccines, or natural infection.

Researchers behind an experimental AI-designed “pan-Sarbecovirus” COVID vaccine recorded 148 separate adverse events among just 39 vaccinated participants during a first-in-human clinical trial published last month in the Journal of Infection.

The vaccine, known as pEVAC-PS, was developed using “Digitally Immune Optimised Synthetic Vaccine” (DIOSynVax) technology and was computationally engineered to target not only SARS-CoV-2, but a broad family of purportedly related bat coronaviruses.

The vaccine was delivered through a needle-free intradermal injection system using the PharmaJet Tropis device.

The mainstream is celebrating the drug as a “world-first.”

However, according to the paper, researchers documented:

  • 121 unsolicited adverse events,
  • 15 adverse events of special interest (AESIs),
  • and 12 clinically significant laboratory adverse events

across only 39 vaccinated participants.

That’s roughly 3.8 total recorded adverse-event entries per vaccinated participant in the small phase I trial.


The study further states that 23 of the unsolicited adverse events were considered “possibly,” “probably,” or “definitely” related to the vaccine.

The paper nevertheless repeatedly describes the vaccine as “well tolerated.”

The paper downplays the severity of the adverse events, but the raw numbers remain notable relative to the tiny sample size—especially given the vaccine failed to demonstrate broad or robust neutralizing activity.

“No serious adverse reactions (SARs), suspected unexpected adverse reactions (SUSARs) or serious adverse events (SAEs) occurred. There were 15 adverse events of special interest, all of which were COVID-19 episodes which were of grade one or two severity and did not require medical attention. There were 121 unsolicited adverse events, all of which were grade one or two severity and 23 were deemed possibly, probably or definitely related to the vaccine. There were 12 laboratory adverse events considered clinically significant, all of which were grade one or two severity and self-resolved without intervention during the study.”

“All four dose concentrations of pEVAC-PS were generally well tolerated.”

Adverse-event burden is being generated in a trial so small that even a modest number of reactions changes the overall safety picture.

The authors do not provide a detailed breakdown of the specific unsolicited adverse events, raising questions about whether the paper’s reassuring “well tolerated” framing would hold up under full public disclosure of the actual reactions recorded during the trial.

Without a transparent symptom-by-symptom breakdown, readers are largely being asked to accept the authors’ safety characterization at face value.

Vaccinated Received Previous COVID Shots, Making Cause of Immunity Impossible to Determine

The trial was conducted between December 2021 and September 2023 and involved healthy adults between ages 18 and 50 who had already received two or three prior COVID-19 vaccine doses.

Since the participants were already heavily pre-immunized before receiving the experimental vaccine, the researchers themselves acknowledge they could not cleanly isolate what immune responses actually came from the new vaccine.

“Interpretation of immunogenicity outcomes was influenced by high baseline antibody levels and heterogeneous exposure histories due to ongoing waves of Omicron variant infections during recruitment, which differed across dose-escalation cohorts and introduced unavoidable immune bias,” the study reads.

The study cannot determine whether any observed immunity came from:

  • the new AI-designed vaccine,
  • prior COVID shots,
  • prior natural infections,
  • or combinations of all three.

That is why the paper ultimately falls back to cautious language like:

  • “modest immunogenicity,”
  • “limited boosting,”
  • and merely “supporting the underlying design concept” rather than demonstrating clear protective efficacy.

The authors acknowledged the findings did “not support a robust vaccine-induced increase in antibody responses beyond pre-existing levels.”

The paper further admits the vaccine failed to produce the intended broad coronavirus immune-boosting effect:

“Although pEVAC-PS was designed to elicit cross-reactive responses against both SARS-CoV-2 and SARS-CoV-1, this intended boosting effect was not observed.”

Researchers additionally acknowledged the vaccine did not demonstrate “broad or robust neutralizing activity.”

Researchers from the University of Cambridge, University of Southampton, Imperial College London, DIOSynVax Ltd, and other institutions participated in the study.

Congress Introduces Billion-Dollar Child Vaccine Control Grid: H.R. 8425


Rep. Schrier’s bill funnels taxpayer cash into Big Pharma, state propaganda, and pediatric surveillance expansion.

Representative Kim Schrier (D-WA) last week introduced H.R. 8425, the “Strengthening the Vaccines for Children Program Act of 2026,” a sweeping federal bill that could funnel billions in taxpayer dollars into an expanded child vaccine control grid.

The legislation does this by deepening federal vaccine infrastructure, increasing payments to vaccine administrators, financially coercing states into running federally approved vaccine propaganda campaigns, and expanding long-term pediatric surveillance systems.

According to campaign finance watchdog OpenSecrets and the Federal Election Commission, Schrier’s donor base includes entities with potential financial or institutional interests in expanded vaccine systems, including:

  • Pfizer
  • Abbott Laboratories
  • Quest Diagnostics
  • Kaiser Permanente
  • American Medical Association

Critics view this as a direct conflict of interest, with pharmaceutical and medical industry donors financially backing a lawmaker whose bill could materially benefit the very corporations and healthcare systems funding her political career.

Rep. Schrier introduced H.R. 8425 alongside original cosponsor Rep. John Joyce (R-PA).

Additional cosponsors include Rep. Suzan DelBene (D-WA), Rep. Josh Riley (D-NY), Rep. Joseph Morelle (D-NY), Rep. Mike Quigley (D-IL), Rep. Henry Johnson (D-GA), and Rep. Grace Meng (D-NY).

You can contact the representatives listed above by clicking through the links in their names.

You can find your representative here and let them know how you would like them to vote on the bill.

H.R. 8425 was immediately referred to the House Committee on Energy and Commerce, where it currently remains in committee after introduction.


Federal Government Uses Medicaid Billions to Pressure States Into Running Vaccine Propaganda

Beginning January 1, 2027, H.R. 8425 offers states a 1% increase in Federal Medical Assistance Percentage (FMAP)—a potentially multi-billion-dollar taxpayer-funded incentive—but only if they comply with federal vaccine messaging mandates.

The bill explicitly states:

“Federal medical assistance percentage determined for each State… under section 1905(b) of the Social Security Act (42 U.S.C. 1396d(b)) shall be increased by 1 percentage point.”

“A State… may not receive the increase… if such State does not ensure culturally competent and effective messages for vaccination outreach to child populations…”

Required messaging includes promotion of:

“advancements in research and vaccine development that have saved millions…”

“the dangers of not being vaccinated…”

“vaccine safety…”

This creates direct federal financial leverage to transform state health departments into taxpayer-funded child vaccine propaganda systems.

Bill Expands Federal Child Vaccine Pipeline Into Millions More Children

The bill broadens federal vaccine system reach by expanding eligibility:

“A child who is enrolled for child health assistance under a State child health plan approved under title XXI.”

This automatically folds CHIP-enrolled children deeper into federally subsidized vaccine programs, expanding the national pediatric vaccine apparatus.

According to the Centers for Medicare & Medicaid Services (CMS), 7,243,961 children were enrolled in CHIP as of December 2025.

Providers Paid Premium Rates to Push Vaccines—Even When Parents Decline

H.R. 8425 guarantees:

“payment for vaccine administration and counseling services… at a rate not less than 100 percent…”

And providers may bill:

“regardless of whether such vaccine is actually administered”

This means taxpayer dollars can directly reward doctors and healthcare systems for vaccine pressure campaigns even when families refuse injections.

Combination Vaccines Become Bigger Big Pharma Revenue Engines

The bill authorizes:

“a separate charge for the administration of and counseling for each component of such vaccine”

This creates stronger reimbursement incentives for expanded multi-component vaccine schedules, potentially increasing pharmaceutical and provider profits.

Pediatric Surveillance Grid Deepened

The legislation authorizes broader access to:

“data, data sets, monitoring systems, delivery systems, and other protected health information…”

CDC must also publicly track:

“vaccination rates… disaggregated by region, age, sex, race, ethnicity…”

This would significantly expand the federal government’s pediatric surveillance grid by increasing institutional access to protected child health data, strengthening vaccine uptake monitoring systems, and building more powerful demographic tracking infrastructure capable of identifying, targeting, and pressuring under-vaccinated populations with greater precision.

Bottom Line

H.R. 8425 is a major federal expansion of a billion-dollar child vaccine control grid that could:

  • Funnel taxpayer money into pharmaceutical and provider systems
  • Financially coerce states into vaccine propaganda compliance
  • Reward providers for vaccine pressure
  • Expand federally managed child vaccine pipelines
  • Build stronger surveillance and demographic compliance tracking systems

For critics focused on medical freedom, parental rights, and government overreach, the bill represents a substantial escalation in the merger of federal power, pharmaceutical profit, and public health surveillance—building the infrastructure today for larger future child vaccine campaigns, broader compliance pressure, and deeper institutional control tomorrow.

$2.46 Billion ‘Momnibus’ Bill Targets Pregnant Women for Vaccination—Builds $715 Million Real-Time Surveillance System Activated During Pandemics. THIS IS EXACTLY HOW IT BEGINS GETTING 100% OF THE POPULATION JABBED WITH THEIR EVIL INJECTION. STARTING WITH THE NEWBORNS!


H.R. 7973, with 203 cosponsors, would create a closed-loop federal system to identify pregnant women by race and demographics, boost their vaccination rates, and track them in real time.

Jon Fleetwood

Apr 06, 2026

A federal bill introduced in Congress would create a system where pregnant women are not only targeted for increased vaccination but also tracked through a federally coordinated surveillance network that activates during pandemics.

H.R. 7973—the “Momnibus Act”—authorizes a staggering $2.46 billion overall, with $715 million of that specifically allocated to build this structure: combining mass vaccination initiatives with a real-time data tracking system designed to monitor health status, outcomes, and demographic characteristics during declared public health emergencies.

The bill constructs a pipeline to identify the population, increase medical intervention, and track the results—continuously, at scale, and under federal coordination.

From a health freedom standpoint, this represents a shift away from individual consent-driven care and toward a system where specific populations are identified, targeted, and monitored during crises.

Introduced by Rep. Lauren Underwood—Backed by Industries Positioned to Benefit

The legislation was introduced on March 18, 2026 by U.S. Representative Lauren Underwood (D-IL-14) and immediately routed to multiple House committees, including Energy and Commerce.

It remains at the earliest stage of the legislative process, with no hearings or votes.

Campaign finance data shows support from healthcare systems, insurance networks, and pharmaceutical-aligned interests—industries that would directly benefit from:

  • expanded vaccination programs
  • increased federal funding streams
  • long-term surveillance infrastructure

The same entities positioned to carry out the bill’s mandates are among those funding its sponsor.

You can contact Rep. Underwood here and the rest of the bill’s 203 cosponsors here to voice your opposition to the expansion of federally directed vaccination targeting, real-time health surveillance during public health emergencies, demographic-based population profiling, centralized control over medical data and response, and the erosion of informed consent and individual medical autonomy.

Federal Government Moves to Identify & Increase Vaccination in Targeted Populations

The bill directs federal agencies to “increase vaccination rates of pregnant and postpartum individuals… and their children.”

Funding is explicitly tied to expanding these efforts, with hundreds of millions authorized specifically for awareness and equity campaigns that prioritize populations with “low rates of vaccination” and “racial and ethnic minority groups.”

The federal government is authorized to identify which groups are not complying with recommended vaccination schedules and focus massive resources on increasing uptake in those populations.

That is a shift from informed consent at the individual level to behavioral targeting at the population level.

$715 Million Surveillance & Vaccine Apparatus Designed for Pandemic Activation

Of the bill’s $2.46 billion total authorizations, $715 million goes directly to the combined maternal vaccine push and surveillance system:

  • $190 million for CDC maternal surveillance system, expanded mortality/morbidity tracking, national pregnancy risk monitoring, and NIH emergency research.
  • The remaining hundreds of millions are dedicated to the maternal vaccination awareness and equity campaign (including the updated $73.4 million per year authorization for 2027–2032).

The system will be used for “data collection, surveillance, and research… as a result of public health emergencies and infectious diseases.”

Real-Time Monitoring of Medical Status During Emergencies

The system tracks “diagnostic testing, confirmed cases, hospitalizations, deaths…” with updates required “at least on a monthly basis.”

This creates continuous, rolling surveillance of a defined population during a declared emergency.

In practical terms, once an emergency is declared, the federal system gains ongoing visibility into who is infected, who is hospitalized, and how individuals are progressing.

That is real-time population monitoring tied directly to health status.

Nationwide Data Integration—From Lab to Federal Database

The bill requires “capacity building… to collect and transmit… demographic data” and mandates that laboratories receive “race, ethnicity, pregnancy status… and other demographic data.”

This creates a standardized data pipeline: data originates at testing sites and hospitals, moves through state systems, and is centralized at the federal level.

Mandatory Demographic Profiling of Health Data

All collected data must be categorized by “race, ethnicity, gender, primary language, geography, socioeconomic status.”

Rather than just tracking disease, the bill would allow tracking of mothers who have the disease, where they are, and what demographic group they belong to.

That enables targeted interventions and creates a framework for population-level categorization tied to medical status.

Centralized Data Collection Before Public Release

The bill requires public reporting on the CDC website while stating “all data collected is deidentified.”

The key distinction is timing.

Data is collected in detailed individual form first, then anonymized before public release.

Federal Authority Expands Immediately After Emergency Declaration

Within 30 days of a public health emergency, “the Secretary shall issue guidance.”

This allows federal officials to control how states collect data, categorize individuals, and manage reporting systems.

A Closed-Loop System: Identify, Intervene, Track

The structure of the bill connects three functions into one system:

  • Identify populations through demographic data
  • Increase vaccination rates within those populations
  • Track outcomes during infectious disease events

This creates a feedback loop where data identifies targets, programs drive intervention, surveillance measures compliance and outcomes.

All operating under federal coordination during a public health emergency.

Bottom Line

H.R. 7973 establishes a federally coordinated $715 million system (within a $2.46 billion bill) that:

  • identifies specific populations of pregnant and postpartum women for increased vaccination
  • tracks their medical status in real time during pandemics
  • categorizes individuals by demographic characteristics
  • integrates data across labs, hospitals, and government systems
  • centralizes authority during declared emergencies

The bill lays the groundwork for a model where medical decisions are no longer purely individual—but increasingly shaped by population-level targeting, centralized guidance, and continuous monitoring during crises.

Missouri Senate Passes Bill Blocking WHO, UN, WEF Authority—’No Foreign Laws Act’ Declares Global Bodies Have ‘No Jurisdiction or Power’ in State

Apr 5

Read full story

Maryland Bill Lets Pharmacists Order Vaccines for You—Logging Your Name in State Tracking System Without Any Patient-Request Requirement

Apr 3

Read full story

NIAID/NIH and USDA Fund Bioengineered Chimeric Influenza Viruses Built Using Pandemic H1N1 Components: Journal ‘Science Advances’

Jon Fleetwood

·Read full story

West Virginia Bill Forces Vaccine History Into Every Sudden Death Under 30: HB4915

Jon Fleetwood

Apr 2

Read full story

Illinois Bill Turns Hospitals Into Mass Influenza Shot Intake Points for Every Adult, Mandates Universal Identification and Targeting System

Mar 30

Read full story

WHO Influenza Plan Orchestrates Global mRNA-Based ‘Next-Generation’ Pandemic Vaccine System Through 2050—46 Vaccines Already Underway

Jon Fleetwood

Mar 27

Only 14% of Positive PCR Tests Meet Study’s Definition of Infection: Journal ‘Frontiers in Epidemiology’


“A PCR-positive test alone can by no means confirm infection,” study authors confirm—yet the test is currently being used to justify government response to bird flu.

Only a small fraction of people who tested positive for COVID-19 by PCR in Germany met researchers’ criteria for infection, according to an October peer-reviewed study published in Frontiers in Epidemiology.

The findings come as PCR tests are being used to justify government response to avian influenza “bird flu,” including animal culling, countermeasures (vaccine) development, and gain-of-function experiments.

After analyzing nationwide laboratory data from March 2020 through mid-2021, the authors of the new study concluded that only 14% of PCR-positive individuals showed evidence of true infection, which they measured by later antibody development.

The remaining majority did not.

“Only approximately 14% of those who tested PCR-positive were actually infected.”

That means 86% of PCR-positive tests did not meet the authors’ definition of infection, calling into question the use of PCR positivity to count disease cases.


The study was conducted by researchers from multiple European universities and research institutes, examining data from Akkreditierte Labore in der Medizin (ALM), a laboratory consortium that conducted roughly 90% of all PCR testing in Germany during the period analyzed.

Rather than attempting to confirm individual infections through culture (showing evidence of physical, growing live virus in lab cells), the researchers compared weekly PCR-positive fractions with subsequent IgG antibody positivity, which they describe as the accepted biological marker of past infection.

“Since 1942, the detection of virus-specific antibodies has been regarded as the methodological gold standard for confirming infection.”

The logic of the analysis was straightforward.

If PCR-positive results were reliably identifying infected individuals, then PCR positivity should closely track the rise in IgG antibodies over time, given the mainstream virological and immunological model.

Instead, the researchers found that the PCR signal had to be scaled down dramatically to match observed antibody levels.

“Fitting the scaled cumulative PCR-positive fraction … yields PPCR ≈ 0.14 … This implies that roughly only one in seven German individuals with a PCR-positive test later had detectable IgG antibodies, that is, was actually infected with SARS-CoV-2.”

The article further notes that this 14% figure may still be an overestimate.

When accounting for possible testing biases, they state that the proportion of PCR positives representing real infections could be even lower.

“A more conservative interpretation of our results suggests that as few as one in eight or even in nine PCR-positive individuals … may have actually been infected.”

In other words, between 86% and 90% of PCR-positive results did not correspond to confirmed infection.

The paper emphasizes that PCR testing does not, by itself, diagnose infection.

“PCR tests merely detect the presence of fragments of viral genetic material, not necessarily an active infection.”

The study also identifies known sources of false-positive PCR results, including laboratory artifacts and statistical effects that become pronounced during mass testing.

“It is therefore important to highlight two known sources of false-positive PCR results.”

One cited example involves PCR-positive signals detected in water-only samples containing no virus at all.

“The Charité’s PCR assay produced positive results on water controls at cycle threshold (CT) values between 36 and 38.”

Beyond laboratory artifacts, the authors explain that even tests designed to be highly accurate at ruling out uninfected people can still produce large numbers of false positives when true infection levels are low.

In this context, “specificity” refers to how often a test correctly returns a negative result in someone who is not infected.

If specificity is less than 100%, some uninfected people will inevitably test positive.

“According to Bayes’ theorem, the rate of false positives increases when disease prevalence declines, owing to test specificity below 100%.”

Using observed positivity rates and their fitted infection estimate, the authors calculate that PCR specificity alone can explain the discrepancy between PCR positives and confirmed infections.

“Assuming 1% of tested individuals were true positives, a specificity of 94% explains the remaining 6% of PCR-positive results as false positives among the 99% who were not infected.”

The study’s findings have direct implications for how COVID-19 “cases” were counted and used in public policy.

Throughout the pandemic, PCR-positive test results were treated as proxies for infection and were used to justify restrictions and emergency measures.

PCR-positive test results are not being used to justify bird flu containment measures around the world.

The article argues this approach lacks biological grounding.

“A PCR-positive test alone can by no means confirm infection at the individual level.”

The paper concludes that Germany’s reliance on raw PCR positivity substantially overstated infection levels and distorted the understanding of the pandemic’s actual course.

“The principal finding from our analysis … is this: only 14%—and possibly even fewer, down to 10%—of individuals identified as SARS-CoV-2-positive via PCR testing were actually infected, as evidenced by detectable IgG antibodies.”

The article argues that PCR positivity was treated as infection when the data showed it overwhelmingly not.

By analysis, PCR positivity does not reliably indicate infection, raising questions about its continued use as a case-defining tool in current and future disease responses.

Gates Pours $3.3M Into mRNA Purification Tech—Admitting COVID Vaccine Impurity Problem as Platform Becomes Permanent


Press release admits current mRNA-based vaccine are not effective enough and contain too many impurities.

Despite mainstream attempts to downplay the alarming contamination problem plaguing COVID-19 vaccines, the Gates Foundation has awarded $3.3 million to a team of scientists at New York’s Rensselaer Polytechnic Institute (RPI) to develop “breakthrough purification technologies” for producing mRNA-based vaccines.

A September Autoimmunity study confirms that both Pfizer-BioNTech and Moderna’s mRNA COVID-19 injections contain many hundreds of times more contamination than the FDA and WHO limit.

The grant is an implicit admission that contamination is in fact a problem posed by mRNA vaccines, as well as a sign that the platform is here to stay.


Gates is funding the project because of the “impurities” and “inefficien[cy]” related to mRNA vaccines.

According to an RPI announcement:

The research team aims to address a critical bottleneck in the production of mRNA therapeutics: the purification process that removes impurities while maintaining the integrity of the therapeutic molecule.

“This project represents a paradigm shift in how we think about mRNA purification,” Belfort said. “Current technologies are prohibitively expensive and inefficient, creating barriers to access for the populations that need them most. Our goal is to develop a purification platform that is not only more cost-effective but also more productive and scalable.”

The researchers aim to accomplish this by “replacing conventional resin-based purification systems with advanced membrane technologies and innovative binding molecules.”

The RPI announcement also admits that current mRNA-based vaccine impurities are linked to side effects and that the injectables are not effective enough, more revelations that cut against mainstream counterclaims.

Higher purity mRNA vaccines with lower immunogenic impurities could lead to improved clinical outcomes, including reduced side effects and enhanced therapeutic efficacy.

The announcement predicts the rise of self-replicating vaccine technology, which this website was the first to warn about in December 2023.

Additionally, the technology being developed could prove particularly valuable for self-amplifying RNA (saRNA) therapeutics, which require lower doses than traditional mRNA vaccines and represent the next generation of RNA-based medicines.

Gates has been developing self-copying mRNA vaccines for COVID (herehere) as well as for bird flu (here), which is the pathogen this website has been predicting will fuel the next orchestrated pandemic.

The billionaire’s latest investment is made in the name of strengthening Big Pharma infrastructure, as well as “equity” and “pandemic preparedness.”

If successful, this technology could enable local production of mRNA vaccines in regions that currently lack access to affordable biomanufacturing infrastructure, supporting global health equity and pandemic preparedness.

Despite the disease, hospitalizations, and deaths linked to mRNA jabs, the technology isn’t going anywhere.

No U.S. Agency Ever Verified the Lung Sample the Chinese Gov’t Built the SARS-CoV-2 Genetic Sequence From


Before injecting it into hundreds of millions of Americans via COVID-19 vaccines.

No U.S. agency has ever verified that the COVID-19 pathogen’s (SARS-CoV-2) genetic code that a Chinese government biolab supplied at the beginning of the COVID-19 pandemic—said to have been sequenced from a pneumonia patient’s lung wash—actually originated from that clinical sample before it was encoded into hundreds of millions of mRNA vaccine doses.

China never provided the physical patient sample to any U.S. institution.

In fact, Beijing issued an official directive forbidding the sharing of any samples and ordering the destruction of those samples.

And the U.S. never demanded or required an analysis of those samples before allowing its citizens to be injected with China’s pathogenic spike protein-producing code.

This critical step in verification was—and still has been—skipped, despite earlier warnings that China’s military had been exploring bioweapons development that integrates biotechnology and genetic engineering into a “new domain of warfare.”

It was also skipped despite EcoHealth Alliance’s 2018 ‘DEFUSE’ proposal to DARPA to collaborate with China to create chimeric coronavirus spike proteins with furin cleavage sites, receptor-binding domain upgrades, and two proline insertions—the defining characteristics of the COVID-19 pathogen and mRNA vaccines.

Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) have confirmed that the COVID-19 pandemic was likely the result of lab-engineered pathogen manipulation—meaning billions were injected with a genetic drug that codes for a Chinese government-constructed, lab-altered spike protein.


How China Made the SARS-CoV-2 Genetic Sequence

The SARS-CoV-2 genetic code was created in a biosafety level 3 (BSL-3) laboratory at the Chinese government-run Shanghai Public Health Clinical Center, using long-debunked (here) reverse-transcription PCR (RT–PCR) technology.

  • Dr. Kary Mullis, the inventor of the PCR test, said in a 1997 interview (here) that his test should not be used to determine whether a patient is infected with a virus.
  • This is because the test “can find almost anything in anybody” if its parameters are set high enough, tainting the results.
  • “Anyone can test positive for practically anything with a PCR test. If you run it long enough… you can find almost anything in anybody,” he said. “It doesn’t tell you that you’re sick.”

A February 2020 Nature publication explains how China created the SARS-CoV-2 sequence:

Here we study a single patient who was a worker at the market and who was admitted to the Central Hospital of Wuhan on 26 December 2019 while experiencing a severe respiratory syndrome that included fever, dizziness and a cough. Metagenomic RNA sequencing4 of a sample of bronchoalveolar lavage fluid from the patient identified a new RNA virus strain from the family Coronaviridae, which is designated here ‘WH-Human 1’ coronavirus (and has also been referred to as ‘2019-nCoV’). Phylogenetic analysis of the complete viral genome (29,903 nucleotides) revealed that the virus was most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses (genus Betacoronavirus, subgenus Sarbecovirus) that had previously been found in bats in China5. This outbreak highlights the ongoing ability of viral spill-over from animals to cause severe disease in humans.

To investigate the possible aetiological agents associated with this disease, we collected bronchoalveolar lavage fluid (BALF) and performed deep meta-transcriptomic sequencing. The clinical specimen was handled in a biosafety level 3 laboratory at Shanghai Public Health Clinical Center. Total RNA was extracted from 200 μl of BALF and a meta-transcriptomic library was constructed for pair-end (150-bp reads) sequencing using an Illumina MiniSeq as previously described4,6,7,8. In total, we generated 56,565,928 sequence reads that were de novo-assembled and screened for potential aetiological agents. Of the 384,096 contigs assembled by Megahit9, the longest (30,474 nucleotides (nt)) had a high abundance and was closely related to a bat SARS-like coronavirus (CoV) isolate—bat SL-CoVZC45 (GenBank accession number MG772933)—that had previously been sampled in China, with a nucleotide identity of 89.1% (Supplementary Tables 12). The genome sequence of this virus, as well as its termini, were determined and confirmed by reverse-transcription PCR (RT–PCR)10 and 5′/3′ rapid amplification of cDNA ends (RACE), respectively. This virus strain was designated as WH-Human 1 coronavirus (WHCV) (and has also been referred to as ‘2019-nCoV’) and its whole genome sequence (29,903 nt) has been assigned GenBank accession number MN908947. Remapping the RNA-sequencing data to the complete genome of WHCV resulted in an assembly of 123,613 reads, providing 99.99% genome coverage at a mean depth of 6.04× (range, 0.01–78.84×) (Extended Data Fig. 3). The viral load in the BALF sample was estimated by qPCR to be 3.95 × 108 copies per ml (Extended Data Fig. 4).

China handed the world a genetic code in computer form (in silico).

And governments all over the world accepted that code without scrutiny.

They allowed billions of people to be injected with a vaccine that creates the Chinese government’s foreign protein in the body for more than 700 days.

China Had the SARS-CoV-2 Sequence ‘More Than Two Weeks’ Before Releasing It

A January 2024 U.S. House Energy & Commerce press release confirms China possessed the SARS-CoV-2 sequence “days before the CCP acknowledged an outbreak, and more than two weeks before the China CDC release[d] their sequence.”

The congressional body said that fact “calls into question how early the CCP knew about the virus and how long they withheld this information from the world.”

This significant discovery further underscores why we cannot trust any of the so-called ‘facts’ or data provided by the CCP and calls into serious question the legitimacy of any scientific theories based on such information. The American people deserve to know the truth about the origins of SARS-CoV-2, and our investigation has uncovered numerous causes for concern, including how taxpayers’ dollars are spent, how our government’s public health agencies operate, and the need for more oversight into research grants to foreign scientists,” said Chairs Rodgers, Guthrie, and Griffith.

My report from last month revealed that before the pandemic, DARPA had developed a program to synthesize viruses purely from digital sequences within in 60 days.

Bottom Line

In the end, the world was locked down and injected on the honor system of a hostile foreign government, and not one U.S. agency has yet produced the single piece of evidence that should have come first: independent proof that China’s digital code ever came from a real human sample.

Will the same national security concern-raising strategy be used in the apparently incoming bird flu pandemic?

How the WHO Dictated the COVID-19 Pandemic and How It’s Already Dictating the Coming Bird Flu Pandemic


A warning for Congress and American citizens.

What follows is a documented sequence showing how the World Health Organization (WHO) seized operational control of the COVID-19 response from day one—and how it is now positioning itself to run the avian influenza pandemic the same way.

Will America follow the WHO into pandemic peril again?

The Timeline

On December 31, 2019, the Chinese government reported a cluster of pneumonia cases in Wuhan, Hubei Province.

On the same day, the WHO commandeered the international vaccine response, issuing its first “emergency use validation for a COVID-19 vaccine” emphasizing the “need for equitable global access” and declaring governments all over the world must “expedite their own regulatory approval processes to import and administer the vaccine”:

“The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago,” reads the organization’s Dec 31 press release.

“The WHO’s Emergency Use Listing (EUL) opens the door for countries to expedite their own regulatory approval processes to import and administer the vaccine. It also enables UNICEF and the Pan-American Health Organization to procure the vaccine for distribution to countries in need.”

“‘This is a very positive step towards ensuring global access to COVID-19 vaccines. But I want to emphasize the need for an even greater global effort to achieve enough vaccine supply to meet the needs of priority populations everywhere,’ said Dr Mariângela Simão, WHO Assistant-Director General for Access to Medicines and Health Products. ‘WHO and our partners are working night and day to evaluate other vaccines that have reached safety and efficacy standards. We encourage even more developers to come forward for review and assessment. It’s vitally important that we secure the critical supply needed to serve all countries around the world and stem the pandemic.’”

“Regulatory experts convened by (the) WHO from around the world and (the) WHO’s own teams reviewed the data on the Pfizer/BioNTech vaccine.”

(The) “WHO is working to support countries in assessing their [COVID vaccine] delivery plans and preparing for use where possible.”

“The emergency use listing (EUL) procedure assesses the suitability of novel health products during public health emergencies. The objective is to make medicines, vaccines and diagnostics available as rapidly as possible to address the emergency while adhering to stringent criteria of safety, efficacy and quality.”

“Once a vaccine has been listed for WHO emergency use, WHO engages its regional regulatory networks and partners to inform national health authorities on the vaccine and its anticipated benefits based on data from clinical studies to date.”

“As part of the EUL process, the company producing the vaccine must commit to continue to generate data to enable full licensure and WHO prequalification of the vaccine. The WHO prequalification process will assess additional clinical data generated from vaccine trials and deployment on a rolling basis to ensure the vaccine meets the necessary standards of quality, safety and efficacy for broader availability.”

The very next day, January 1, 2020, the WHO set up its IMST (Incident Management Support Team), putting the organization “on an emergency footing for dealing with the outbreak,” according to the WHO’s own published timeline.

On January 5, the WHO published its first “Disease Outbreak News” on the new purported virus, which represented a “flagship technical publication to the scientific and public health community as well as global media” and gave “a risk assessment and advice” to governments, public health officials, and the mainstream international scientific community.


    A Pathogen In Silico

    On January 7, the Chinese government claimed to have identified a brand new coronavirus as the causative agent of the outbreak.

    On January 10, China’s Center for Disease Control and Prevention (China CDC) publicly released what they said was the genetic sequence for the SARS-CoV-2 pathogen, named Wuhan-Hu-1.

    • The sequence was in silico only, meaning it was in a purely digital format shared on computers, as confirmed by Nature journal.
    • China said they produced the code from a sick man’s lung fluid using long-debunked (here) PCR technology.
      • Dr. Kary Mullis, the inventor of the PCR test, said in a 1997 interview (here) that his test should not be used to determine whether a patient is infected with a virus.
      • This is because the test “can find almost anything in anybody” if its parameters are set high enough, tainting the results.
      • “Anyone can test positive for practically anything with a PCR test. If you run it long enough… you can find almost anything in anybody,” he said. “It doesn’t tell you that you’re sick.”
    • Without any deep, long-term analysis of China’s sequence, this in silico code was accepted by governments and the international scientific community, becoming the blueprint for every coronavirus vaccine.
      • Billions were injected with the code, whether in the form of Pfizer and Moderna’s mRNA platform, or Johnson & Johnson’s and AstraZeneca’s immortalized-aborted-fetal-cell-based (HEK 293, PER.C6) viral vector vaccines.
      • Governments all over the world and Big Pharma manufacturers trusted China without question, despite warnings that China’s military had been exploring bioweapons development that integrates biotechnology and genetic engineering into a “new domain of warfare.”
      • No vaccinated person was given informed consent—never told these vaccines were based on a code produced by the Chinese government.
      • No COVID vaccine manufacturer has ever published the full genetic sequence of their COVID-19 vaccines on their own corporate websites or in standalone manufacturer-authored scientific papers.
      • No government or COVID vaccine manufacturer has ever published a genetic alignment between the spike protein their injections force the body to produce and the purported “wild” SARS-CoV-2 spike protein, in order to confirm the foreign protein our cells make post-vaccination is the “correct” one.
      • The University of Cambridge’s Medical Research Council (MRC) Toxicology Unit revealed that COVID vaccines cause the body to produce “rogue” proteins due to a “glitch” in the cellular process called ‘frameshifting,’ which stimulates an “unintended immune response in the body.”
      • No government or COVID vaccine manufacturer has ever published the full sequences of the plasmids used to make their injections.
      • Documents show that every defining structural anomaly of SARS-CoV-2—the furin cleavage site, the rebuilt human-binding motif, and the ACE-2-critical Q498 residue—matches specific pre-pandemic engineering plans and mutagenesis experiments documented in DEFUSE and earlier coronavirus manipulation studies (hereherehereherehere).
      • Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) have confirmed that the COVID-19 pandemic was likely the result of lab-engineered pathogen manipulation—implying billions were injected with a genetic drug that codes for a lab-altered spike protein structurally tied to the very experiments now implicated in the pandemic’s origin.
    • Pfizer’s own study data confirms over 1,200 diseases linked to COVID mRNA jabs, and the CDC’s Vaccine Adverse Event Reporting System (VAERS) documents 38,773 COVID-vaccine-linked deaths and 1,666,646 adverse events—though these represent fewer than 1% of actual vaccine injuries, according to a federally funded Harvard Pilgrim study.

    On the same day (Jan 10), the WHO began using the phrase “2019 Novel Coronavirus” or “2019-nCoV” to refer to the disease.


    WHO Rubber-Stamps China’s COVID Sequence—Big Pharma & Int’l Scientific Community Obey

    On January 11, the WHO announced that it had received the Chinese government’s SARS-CoV-2 genetic sequences.

    On January 12, the WHO officially endorsed China’s in silico coronavirus sequence:

    “On 11 and 12 January 2020, WHO received further detailed information from the National Health Commission about the outbreak,” a press release reads.

    “WHO is reassured of the quality of the ongoing investigations and the response measures implemented in Wuhan, and the commitment to share information regularly.”

    Vaccine developers, including those at Moderna and Pfizer-BioNTech, initiated vaccine design within hours of the sequence becoming available, and diagnostic assays were developed within days.

    The transnational scientific community accepted the sequence, leading to immediate action in diagnostics, vaccine development, and surveillance, with minimal skepticism or delay.

    On January 22, the WHO convened an emergency committee to assess the outbreak.

    By January 30, it declared the outbreak a Public Health Emergency of International Concern (PHEIC), advising all countries to prepare for containment, which included doomed social distancing and isolation measures, as well as the “rapid development and access” to vaccines.

    WHO Declares a ‘Pandemic’

    On March 11, the WHO became the first international body to officially declare the COVID-19 outbreak a global “pandemic” and, despite being a foreign and unelected body, began dictating what countries should do:

    “We have called every day for countries to take urgent and aggressive action.”

    Countries should “detect, test, treat, isolate, trace and mobilise their people in the response.”

    “We’re calling on you to activate and scale up your emergency response mechanisms.”

    “Communicate with your people about the risks and how they can protect themselves.”

    “Find, isolate, test and treat every case and trace every contact.”

    “Ready your hospitals, protect and train your health workers.”

    “Countries must take a whole-of-government, all-of-society approach.”

    “We cannot say this loudly enough or clearly enough or often enough; all countries can still change the course of this pandemic.”

    “We are not suggesting to shift from containment to mitigation; we are not, we underline that.”

    “All countries need to review their strategies right now.”

    “Surveillance systems have to improve.”

    “There’s no excuse to say that we cannot do this.”

    “Countries must… take urgent and aggressive action.”


    The Power & Peril of WHO-Dictated ‘Scientific Consensus’

    In short, the WHO declared what would be the “scientific consensus” regarding COVID-19, and the international mainstream scientific community followed suit.

    • Because this mainstream supranational scientific establishment acted in lockstep with the WHO, there was no need for consent from the world’s citizenry or official government policy.
    • That’s the power of the WHO and internationally curated “scientific consensus,” no matter how fabricated and fraudulent that consensus might be.
    • The COVID pandemic proved that the WHO and scientific community—an infinitesimally small group of elite multinational agents—can make the world bend to their will.

    After its two-year investigation into the COVID-19 pandemic, the Congressional Select Subcommittee on the Coronavirus Pandemic confirmed that the WHO’s draconian authoritarianism throughout the pandemic “was an abject failure,” writing:

    “The WHO’s response to the COVID-19 pandemic was an abject failure because it caved to pressure from the Chinese Communist Party and placed China’s political interests ahead of its international duties. Further, the WHO’s newest effort to solve the problems exacerbated by the COVID-19 pandemic—via a “Pandemic Treaty”—may harm the United States.”

    But there is no need for a treaty, no matter how national-sovereignty-degrading, when the world’s public health leaders and self-appointed scientific elite unquestioningly carry out the WHO’s bidding.

    Bottom Line

    The WHO is right now orchestrating a coming avian influenza “bird flu” pandemic.

    The WHO has already:

    Simultaneously, governments all over the world are performing reverse-genetics gain-of-function (GOF) experiments on- and developing countermeasures (vaccines, etc.) for bird flu (see links below).

    Just as they were before the COVID pandemic.

    The Trump administration has been “actively participating” in WHO bird flu seminars despite the president’s January 2025 executive order to withdraw from the organization.

    The admin’s $500 million ‘Generation Gold Standard’ platform is focused on bird flu vaccine development.

    If the WHO repeats its COVID plan with avian influenza, we will see the same rapid lockstep activation of a prebuilt command system—instant acceptance of an unverified digital genome, accelerated vaccine deployment, suppressed dissent, and a global population maneuvered once again into mandatory genetic countermeasures before independent validation is possible.

    U.S. officials and American citizens must decide now whether they will permit this system to run again, or whether they will finally impose the oversight and resistance that were absent the first time.

    WHO Rolls Out ‘Future’ COVID Pandemic Plan Using U.S. Labs for ‘Global Sentinel Surveillance’—Even After Trump Ordered Withdrawal


    Unelected foreign body believes coronavirus still has the “capacity to trigger epidemics and pandemics.”

    The World Health Organization (WHO) has released a “new strategic plan for the management of coronavirus disease threats,” according to a Wednesday press release.

    The announcement comes after the WHO, with Gates Foundation funding, published its blueprint for a supranational digital ID system that tracks every person on Earth from birth, merges vaccine status with income, ethnicity, and religion, and deploys AI-driven surveillance to identify, target, and monitor entire populations.


    Per today’s press release, the WHO wants to control how sovereign nations respond to “COVID-19, Middle East respiratory syndrome (MERS), and potential new coronavirus diseases.”

    The plan “encompasses both routine management as well as emergency scenarios” involving the “emergence of a new coronavirus with pandemic potential.”

    The unelected international foreign body emphasizes that the move represents “the first such unified plan.”

    The goal is “sustained, long-term, and integrated management.”

    WHO says it’s doing this in the name of “advancing integration, sustainability, and equity,” common globalist-tied tropes.

    The plan is part of the organization’s “2025–2030” agenda for national health authorities to participate in an “action-oriented approach to managing coronavirus disease threats in the broader context of infectious disease management.”

    WHO’s justification is the coronavirus’s alleged “capacity to trigger epidemics and pandemics.”

    WHO insists that “uncertainties persist around virus evolution and long-term impacts of COVID-19.”

    One WHO director explained that the plan also lumps in efforts regarding influenza, the pathogen that this website has been warning readers is currently being dangerously manipulated in government-funded laboratories all over the world.

    The director urged government leaders to prepare for “future” pathogenic threats by falling in line with the WHO:

    “Coronaviruses remain one of the most consequential infectious disease threats today,” said Dr Maria Van Kerkhove, WHO Acting Director for Epidemic and Pandemic Management. “Integrating their management into broader respiratory disease and infectious threat prevention and control programmes, including for influenza, is essential. While each country will have its own approach tailored to its national context, WHO urges Member States to use the strategic directions set out in the plan to build resilient health systems that can effectively manage current threats while preparing for future ones.”

    The WHO is expanding its CoViNet “sentinel surveillance” network, now comprised of 45 laboratories.

    Eleven labs were added this year alone, signifying the magnitude of the operation.

    “To strengthen global coronavirus monitoring, WHO has also expanded its Coronavirus Network (CoViNet), a network of disease surveillance programmes and reference laboratories for SARS-CoV-2, MERS-CoV, and emerging coronaviruses of public health significance. CoViNet now includes 45 national reference laboratories across the human, animal, and environmental health sectors, with 11 laboratories added in 2025. CoViNet complements WHO’s Global Influenza Surveillance and Response System (GISRS), which conducts global sentinel surveillance, including for SARS-CoV-2.”

    Despite President Donald Trump’s January executive order withdrawing the U.S. from the WHO, CoViNet includes labs belonging to Emory University, Ohio State University, and the Centers for Disease Control and Prevention (CDC).

    In short, the WHO’s new “strategic plan” represents an international effort to centralize pandemic authority under an unelected foreign body, erode national sovereignty, override accountability, and collapse public-health decision-making into a global command structure.

    And it comes even after President Trump formally withdrew the United States from the WHO, underscoring how deeply these surveillance and biosecurity networks remain embedded—and how ripe they are for further abuse.

    mRNA Jabs: The Deadly Gift That Keeps On Giving


    No one who understands the politics of ‘the science’ trusts it or will allow a gene therapy bioweapon into their bodies or of those they love and care for. Why are these shots still available?

    Aussie17 writes a great blog. Below is posted Part 1 of his [?]/her [?] vitally important and compelling 2-part series linking the COVID jabs, through clean, reliable data from Singapore, with the one and only medication for a previously rare, devastating, invariably fatal disease called Amyotrophic Lateral Sclerosis (ALS).

    There is only one use for the particular drug followed in the stack: ALS. Since the people taking it are ALS patients who have a short lifespan, if more is sold because more people are taking it. That can only be because more people have ALS.
    Q: Why do more people have ALS, decreased fertility, auto immune diseases, turbo cancer and excess death?
    A: ABTS [Anything but the shots]

    It is urged that you read these two pieces and do several things: first, commit to being the voice of truth about these indescribably dangerous weapons against humanity disguised as “vaccines”. They are not. And clean statistics from around the world make that horrifyingly clear. Only governments and their lackies can find any way to deny this. It is up to us, all of us, to amplify this message.

    Second, commit to doing whatever is necessary to protect your own body and that of people you have control over (parents for minor children, for example).

    That means never, ever [again?] permit this or any other “untested” government-provided miracle snake oil substance into your body (or theirs).

    Vintage Salesman GIF by Challenger

    Third, in order to educate yourself, and check out the idea that every aspect of our lives is already permeated by the United Nations parasite, perform this quick experiment: using the search engine of your choice, enter the following (filling in the blank with your town or agency impacting your profession or State or Province or country):
    ” List, with references and links, all of the UN-derived, UN-compliant, UN-related or UN-adjacent programs, policies, protocols, policies and partnerships which impact directly or indirectly [fill in the blank].”

    It is promised that that your jaw will be somewhere in the vicinity of your knees when you see what comes back.

    Now here is Part 1 of Aussie17’s important correlation of deeply meaningful information:

    PharmaFiles by Aussie17

    The Jab That Keeps on Giving…300% Increase in ALS(Motor Neuron Disease) Drug sales reveals Singapore’s Hidden Health Horror Story!

    A big part of Big Pharma is spinning a good story around sales numbers for the bosses. Nail the narrative, and you’re golden for another year. Botch it, and you’re packing your desk.

    Why is this important? Well, for quite a few reasons, but a big one is because, especially in light of Dr. Prasad’s letter acknowledging that Covid jabs kill kids, with the mRNA shots still on the market and new mRNA jabs, including the uber-deadly replicon shots, being approved all the time, especially for kids (and, thanks to Merck, for your pets, too), we are dealing with weak-kneed damage control, not the beneficent or beneficial regulatory service to the public. We pay for regulation, not rubber-stamped death and disease but that is what we get.

    Doin’ the Ol’ “HHS is Here for You, Regulating to Protect Your Health, Bobby Kennedy’s Our Guy” Rag

    Let it be clear: Bobby knows full well that mRNA jabs are bioweapons. Prasad knows. Bhattacharya knows. There is, and has never been, a dearth of knowledge of how deadly these shots are. Pfizer and Moderna know. So does the Department of Defense.
    Anyone who genuinely cares about ending the REAL pandemic, not the COVID propagandemic nonsense, but the deadly reality of the medical murders and the public health harms and, most of all, the bioweapon jabs, would not play nice, bide his time and be a good politician. He would move heaven and earth to end the deadly scourge of gene editing, death dealing weapons killing and maiming us while they destroy our ability to reproduce humankind.

    Or he could pretend to be working on it and not accomplish anything even coming close to protecting the public from the bioweapon.

    Hey, Mr. Secretary (and Mr. President), did you get caught with your regulatory pants down? Well, just keep on doing what you have done for nearly a year: pretend you are doing performance art and you really meant to be in that awkward position and indicate how much thought went into getting your rear end exposed.

    That’s the science we are supposed to trust, after all. And we had that revelation about autism to trust, too. Now that was some seriously trustworthy science, right?

    Then, because the public let you get away with that, you can just keep on doing more of same, right?

    But don’t, for God’s sake, waste all the time and money and creativity that has gone into this decades long, untold trillions of dollars’ worth of bioweapon program by interfering with it! No, Siree Bob! Cover your tracks first, lie out of every orifice you and your associates can make any sounds out and keep the bioweapons in the rapid approval pipeline.

    Most important of all, of course, cover your own ass if you can manage it, and keep on doing what you’re doing.

    Maybe nobody will notice while they are exterminated from the bioweapons on the shelves and in the clinics.

    Or maybe we will. And maybe we will eject the deadly UN parasite from every cell in the Body Politic and make some real headway to recovery

    Nothing less.

    And neither the head of the Executive Branch of the US government nor his appointee over at Health and Human Services has done so. Meanwhile, we suffer and die through an entirely man-made plague.

    As it turns out, hiding it in Singapore is quite difficult. Thus, this outstanding two-part revelation.

    Who is behind it? The genocidal maniacs who think you and I are disposable at their whim and pleasure. That’s right: the globalist parasites who operate the United Nations for their pleasure and profit, and for our pain and punishment. We, after all, are the carbon they intend to eliminate.

    The solution? a good, comprehensive detox to get the UN and its bits and pieces out of our lives, our bodies, our government, our schools, our town halls, our clinics and hospitals, our airports, our banks and everywhere else.

    Learn more, a lot more, at PreventGenocide2030.org.

    WHO, CDC, Gates, and Oxford Were Used to Test Public ‘Compliance’ Strategies for ‘Lower-Quality Vaccines’ Before Any COVID-19 Jabs Existed: ‘PLOS Glob Public Health’ Journal


    Raising manipulation concerns.

    A newly published PLOS Global Public Health paper confirms that researchers were already running multinational experiments to measure how quickly populations could be moved toward COVID-19 vaccination before any product had been authorized.

    The authors state clearly:

    “We recruited the respondents in late November 2020… before any [vaccines] were officially approved by a government.”

    This places the experiment at a time when the public had no approved vaccine, no final safety data, and no access to Phase 3 trial results.

    Yet the study was already testing which institutions—WHO, CDC, Oxford, or the Gates Foundation—were most effective at accelerating public willingness to accept a future vaccine.


    The Experiment Focused on Uptake Speed, Not Evidence

    The survey’s main outcome variable was not clinical.

    It was the speed of compliance:

    “Respondents were given five options to express whether and when they would choose to get vaccinated if a vaccine were available at no cost. These options were: ‘Yes, within a month,’ ‘Yes, within 2-3 months,’ ‘Yes, within 4-12 months,’ ‘Yes, after a year,’ and ‘No, never.’”

    Those responses were then collapsed into:

    • “early” (within 3 months)
    • “middle” (4–12 months)
    • “late,” which includes “never”

    The paper describes vaccine hesitancy entirely in terms of “delay”:

    “WHO endorsements, alongside the three other public health organizations examined in this study, are associated with a statistically significant, cross-national reduction in vaccine hesitancy, measured as the delay between vaccine availability and willingness to receive it. Our timing-based measure is a meaningful, yet under-studied, dimension of vaccine uptake that directly speaks to the urgency of public health communication during a pandemic.”

    The study did not attempt to measure why individuals might wait for more data or how safety information influences decisions.

    Hesitancy was defined only as slowness to accept.

    Endorsements Were Randomized to Test Which Authority Moves People Faster

    The authors explain that each participant was shown randomized vaccine profiles with or without endorsements from major institutions:

    “Our experiment randomly varied exposure to vaccine endorsement information from several prominent global health governance players, including the WHO, the Centers for Disease Control and Prevention (CDC), Oxford University, and the Gates Foundation.”

    The goal was to quantify the effect of each authority on changing timing behavior:

    “WHO endorsements increase individuals’ willingness to get vaccinated more quickly.”

    This design treats institutional influence itself as the variable of interest, not the vaccine.

    “[T]rust in scientific authorities, including the WHO, positively correlates with increased public willingness to engage in recommended health practices, such as COVID-19 vaccination and compliance with preventive measures.”

    The Paper Acknowledges the Experiment Took Advantage of High Uncertainty

    The authors state that their framework relies on the public’s vulnerability during uncertain periods:

    “During a novel pandemic, significant uncertainty drives individuals to seek expert guidance on preventive measures such as vaccination.”

    The experiment uses that uncertainty to measure which voice is most persuasive.

    WHO Was Most Effective When It Spoke Early, Before Other Actors

    One of the clearest findings is that WHO’s influence is strongest when it is the first or among the first endorsers:

    “The WHO has the greatest impact when it is the first (or among the first) of many organizations to endorse a vaccine.”

    And that power drops once other organizations join in:

    “[T]he impact of WHO endorsements decreases as additional endorsements from other reputable global health actors emerge.”

    The authors explicitly describe this as substitutability, meaning WHO’s influence is higher only when information from other actors is absent.

    The Study Also Examined How Endorsements Help Drive Uptake of ‘Low-Quality’ Vaccines

    A section of the paper focuses on vaccines with:

    • 50% efficacy,
    • 1-year protection duration,
    • 1 in 10,000 severe side-effect rate,
    • 1 in 30 mild-side-effect rate,

    which the authors classify as low-quality vaccines.

    The paper states:

    “[I]t is crucial to examine the influence of WHO endorsements specifically for lower-quality vaccines, as vaccination intentions for these vaccines are likely to be more sensitive to credible endorsements.”

    Their simulation results showed:

    “[F]or low-quality vaccines… When people are receptive to WHO endorsements, we observe a distinctly higher vaccination rate over time.”

    This shows the study’s purpose was not limited to hypothetical best-case vaccines.

    The authors tested how institutional messaging can increase uptake even when vaccine performance is weak.

    The Authors Describe Their Work as Global-Level Persuasion Research

    Throughout the paper, the focus is on influence, not clinical evaluation:

    “This study investigates the influence of World Health Organization (WHO)’s endorsements…”

    Endorsements “can accelerate vaccination intentions” and “significantly reduce vaccine hesitancy.”

    And the authors frame the absence of evidence as an opportunity:

    “During a novel pandemic, significant uncertainty drives individuals to seek expert guidance on preventive measures such as vaccination.”

    Rather than studying data quality or risk–benefit communication, the study treats this moment of uncertainty as the condition under which endorsement effects can be most accurately measured.

    Conclusion

    The record in PLOS Global Public Health shows that researchers in Canada, Japan, and the United States were already measuring which institutions could most effectively accelerate COVID-19 vaccine uptake—for low-quality vaccines—in November 2020, prior to any approved product.

    The experiment centered on how quickly people could be influenced to vaccinate, how endorsement messaging changes compliance timing, and how those effects behave under uncertainty or when evaluating lower-quality vaccines.

    Every element of the study was built around institutional persuasion.

    Not safety, not efficacy, and not informed consent.

    When institutions are tested for their ability to speed compliance before safety data even exists, the line between public health guidance and psychological manipulation becomes impossible to ignore.